Zulueta, Zulueta L.
HRN: 19-21-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/11/2022
CEFUROXIME 500MG (TAB)
08/11/2022
08/17/2022
PO
500mg
BID
Episiorrhaphy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes